Cited by 57Thyroid Disorders and TreatmentsCardiovascular Function and Risk FactorsCardiac electrophysiology and arrhythmias

Effects of TSH-suppressive therapy on cardiac morphology and function: beneficial effects of the addition of beta-blockade on diastolic dysfunction

Gullu, S, Altuntas, F, Dincer, I, Erol, C, Kamel, N·2004·European Journal of Endocrinology

Abstract

OBJECTIVE: To investigate the effects of long-term levothyroxine (LT4) suppressive therapy on the heart and the effects of beta-blockade on cardiac functions. DESIGN: Twelve female patients receiving LT4, selected from a group of patients with TSH levels of 0.1-0.4 microU/ml, were evaluated. The control group consisted of 11 healthy subjects and 12 patients with TSH levels <0.05 microU/ml. METHODS: Cardiac evaluation consisted of a 12-lead electrocardiogram and an echocardiographic study. Left ventricular mass index (LVMI), isovolumetric relaxation time (IVR), left ventricular end systolic (LVESD) and diastolic diameters, early (VE) and late (VA) diastolic flow velocities and fractional shortening were evaluated. Exercise capacity was assessed with a bicycle ergometer. Both work load and maximal exercise time were measured. Atenolol was given to the patient group at a dosage of 50 mg/day for 3 months and evaluations were repeated. RESULTS: On basal evaluations, LVMI (96+/-17 vs 78+/-21 g/m(2)) and IVR (101+/-9 vs 91+/-4 ms) were found to be increased in the patients taking LT4 (P<0.01). LVESD was also lower than controls (P<0.05). A decrease in VE and an increase in VA were also observed in the patients (P<0.01). IVR decreased after atenolol (92+/-10 vs 101+/-9 ms, P<0.05). LVMI decreased and VE and VA improved but did not reach statistical significance after beta-blockade. Baseline work load and maximal exercise duration were significantly lower in the patients and improvements were observed after atenolol treatment. CONCLUSIONS: These results indicated that cardiac dysfunction may occur even when TSH is suppressed to 0.1-0.4 microU/ml with LT4. beta-blockade improved the cardiac functions.

Integrity signals

Registry

Crossref · 10.1530/eje.0.1500655

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some studies suggest that cardioselective β-blockers or treatment of SHyper with ATDs may improve symptoms, heart rate and supraventricular arrhythmias in patients with grade 2 SHyper.

    “Some studies suggest that cardioselective β-blockers [47,48] or treatment of SHyper with ATDs [46,67] may improve symptoms, heart rate and supraventricular arrhythmias in patients with grade 2 SHyper.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gullu, S., Altuntas, F., Dincer, I., Erol, C., & Kamel, N.
Affiliations
Ankara University (TR)
Venue
European Journal of Endocrinology
Published
2004-05-01
Volume
150
Issue
5
Pages
655-661
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2111593555
Cited by
57
References
31
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 6 · 2012: 5
FWCI
2.69
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
TSH suppression, levothyroxine, beta-adrenergic blockade, atenolol, diastolic dysfunction, left ventricular mass, left ventricular hypertrophy, isovolumic relaxation time, exercise capacity, cardiac function, subclinical hyperthyroidism
MeSH terms
Adrenergic beta-Antagonists, Adult, Atenolol, Blood Flow Velocity, Coronary Circulation, Diastole, Echocardiography, Exercise Test, Female, Heart, Heart Rate, Humans, Middle Aged, Myocardial Contraction, Myocardium, Physical Endurance, Stroke Volume, Systole, Thyrotropin, Thyroxine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review